+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06256575

Randomized Study of Diosmin for Healing Finger Ulcers in Systemic Sclerosis with Placebo Comparison

Led by Primus Pharmaceuticals · Updated on 2026-09-11

45

Participants Needed

5

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and healing effects of diosmin in patients with systemic sclerosis also known as scleroderma who have open sores on their fingers called digital ulcers. This randomized, double-blind study will involve 21 to 45 participants, with two out of every three receiving the active diosmin treatment. The study aims to understand how diosmin may help heal these ulcers and improve patient outcomes. Participants will be randomly assigned to one of two groups one group will receive diosmin tablets twice daily, and the other will receive placebo capsules twice daily, both for eight weeks. The study includes four visits across this 8-week period. At each visit, physical exams and photographs of the ulcers will be taken, and participants will answer questions about their pain levels and lifestyle changes. Throughout the study, researchers will monitor the number and percentage of ulcers that heal at specific time points. They will also track any adverse events to assess safety. Participants can expect to attend four visits over eight weeks, during which they will undergo exams, photo documentation, and pain and lifestyle questionnaires to help evaluate the treatments effects.

CONDITIONS

Brief Title

Study of Diosmin for the Treatment of Digital Ulcers in Systemic Sclerosis

Research Team

L

Lukban

M

Mary L Sanstead

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here